thirty patients undergoing allogeneic bone marrow transplantation ( bmt ) for hematologic malignancies received ciclosporin a ( cs-a ) as prophylaxis of graft-versus-host disease ( gvhd ) .
C0010592
ciclosporin a
C0018133
graft-versus-host disease